CLINICAL_TRIALS
trial_result
· 2024-10-02
Clinical Trial Update: Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury [Phase 3]
Summary
Phase 3 trial evaluating intravenous progesterone for efficacy and safety in severe traumatic brain injury has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: BHR Pharma, LLC | Conditions: Brain Injuries | Phase 3 | Status: COMPLETED | Results posted: 2024-10-02